TrialLancet (London, England)2022

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial.

Byeong-Keuk Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.